Clinical Trial Update: Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating tivantinib in adults with inoperable hepatocellular carcinoma after one prior therapy has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• tivantinib (tivantinib)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2020-07-15